The mode of action of pleuromutilin derivatives. Effect on cell-free polypeptide synthesis.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001665:Binding Sites; D002474:Cell-Free System; D002701:Chloramphenicol / Q000494:pharmacology; D003090:Coliphages; D004151:Dipeptides / Q000096:biosynthesis; D004224:Diterpenes / Q000494:pharmacology*; D004926:Escherichia coli / Q000378:metabolism*; D006160:Guanosine Triphosphate / Q000378:metabolism; D046911:Macromolecular Substances; D008715:Methionine / Q000378:metabolism; D010452:Peptide Biosynthesis; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010445:Peptide Elongation Factors; D010649:Phenylalanine / Q000378:metabolism; D011072:Poly U / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology; D012343:RNA, Transfer / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism
D000900:Anti-Bacterial Agents; D004151:Dipeptides; D004224:Diterpenes; D046911:Macromolecular Substances; D010445:Peptide Elongation Factors; D012367:RNA, Viral; D011072:Poly U; D010649:Phenylalanine; D011691:Puromycin; D002701:Chloramphenicol; D006160:Guanosine Triphosphate; D012343:RNA, Transfer; D008715:Methionine